)
)
J. Molner Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from J. Molner AS
Access all reports
J. Molner AS is a pharmaceutical company based in Tallinn, Estonia, specializing in the development and provision of generic drugs, particularly sterile injectable and dermatology formulations. The company serves pharmaceutical markets in the United States, Canada, and Europe. In addition to drug development, J. Molner AS offers analytical chemistry services, European market release support, and ongoing stability solutions for its clients. The company is headquartered in Tallinn, Estonia, and its shares are listed on the Nasdaq Tallinn.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
MOLNR
Country
🇪🇪 Estonia